Does the doctrine of equivalents apply to novelty? By Eibhlin Vardy on Tuesday, October 31, 2017 Actavis v Eli Lilly arrow declaration doctrine of equivalents expert evidence generics mylan novelty Synthon Teva Yeda +
Colourless Copaxone in the clear: Teva's synthesis patents held to be (mostly) valid By Darren Smyth on Thursday, May 21, 2015 copaxone expert evidence glatiramer acetate insufficiency inventive step novelty patent purity squeeze Synthon Teva validity +